Dr. Nirmish R. Shah
Overview
As director of Duke’s sickle cell transition program, my practice and research focuses on treating children and adults with sickle cell disease. When I work with children, I try to focus on teaching them about their condition and how to transition successfully to living with the disease as an adult. For all patients, I focus on providing the medical, social and psychological support they need to remain healthy. My research aims to increase engagement of sickle cell patients with their own care using mobile technology. Through the use of applications, we’re hoping to help patients, specifically children, better manage their symptoms and medications. Outside of work, I have a strong interest in art. In fact, one of my undergraduate majors was biological illustration. I enjoy drawing plants, animals and people. I’ve recently started getting back into this hobby.
Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.
His clinical research consists of co-authoring 125 peer reviewed articles and participating in 12 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has participated in 1 clinical trial in the study of Thrombocytopenia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
40 Duke Medicine Cir, Durham, NC 27710
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
12 Clinical Trials
Duke Hematology Clinic - Clinic 1E
Gowthami Arepally is a Hematologist in Durham, North Carolina. Dr. Arepally has been practicing medicine for over 36 years and is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. Her top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).
Duke Hematology Clinic - Clinic 1E
I primarily see patients who have a variety of rare bleeding and clotting disorders. I see both older and younger patients and also provide help when patients need to transition to and away from blood thinners. Doctors usually refer patients to me. I try to work with each patient so they understand why they are seeing me and what is going on with their body. I enjoy when a patient can leave my office with a complete understanding of what is going on and what they need to do to get better. As a young child, I had bad allergies and spent much time in the doctor’s office. As a frequent patient, I enjoyed spending time around medicine. As I entered college, I found that I enjoyed chemistry and that hematology allowed me to combine lab work with patient care. Dr. Ortel is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Venous Thromboembolism (VTE), Antiphospholipid Syndrome, Thrombocytopenia, Deep Vein Thrombosis, and Thalamotomy.
Duke Health Integrated Practice Inc
Ara Metjian is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Metjian is rated as a Distinguished provider by MediFind in the treatment of Thrombocytopenia. His top areas of expertise are Purpura, Thrombocytopenia, Blood Clots, and Thrombotic Thrombocytopenic Purpura. Dr. Metjian is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- AnemiaDr. Shah isElite. Learn about Anemia.
- Congenital Hemolytic Anemia
- HemoglobinopathyDr. Shah isElite. Learn about Hemoglobinopathy.
- Hemolytic AnemiaDr. Shah isElite. Learn about Hemolytic Anemia.
- Sickle Cell DiseaseDr. Shah isElite. Learn about Sickle Cell Disease.
- Advanced
- Chronic PainDr. Shah isAdvanced. Learn about Chronic Pain.
- Hemoglobin C DiseaseDr. Shah isAdvanced. Learn about Hemoglobin C Disease.
- Hemoglobin E DiseaseDr. Shah isAdvanced. Learn about Hemoglobin E Disease.
- Hemoglobin SC DiseaseDr. Shah isAdvanced. Learn about Hemoglobin SC Disease.
- Experienced
- Adult Immune ThrombocytopeniaDr. Shah isExperienced. Learn about Adult Immune Thrombocytopenia.
- Aplastic AnemiaDr. Shah isExperienced. Learn about Aplastic Anemia.
- Beta ThalassemiaDr. Shah isExperienced. Learn about Beta Thalassemia.
- Bone Marrow TransplantDr. Shah isExperienced. Learn about Bone Marrow Transplant.
- Hemangioma Thrombocytopenia Syndrome
- Hemolytic CrisisDr. Shah isExperienced. Learn about Hemolytic Crisis.